FDA Amgen Receives Untitled Letter for Banner Ad Promoting Neulasta Thomas Sullivan Aug 31, 2021 0 The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) recently sent an untitled letter…
